<DOC>
	<DOCNO>NCT00685165</DOCNO>
	<brief_summary>The purpose study compare bioequivalence test formulation primidone tablet equivalent oral dose commercially available Mysoline® ( primidone tablet ) adult subject fasting condition .</brief_summary>
	<brief_title>Fasted Bioequivalence Study Primidone Tablets Mysoline Tablets</brief_title>
	<detailed_description>The purpose study compare bioequivalence test formulation primidone tablet equivalent oral dose commercially available Mysoline® ( primidone tablet ) adult subject fasting condition . Twenty-two healthy , non-smoking , non-obese male female volunteer least 18 year age randomly assign crossover fashion receive two primidone dose regimen sequence 14 day washout period dose period . On morning Day 1 , overnight fast least 10 hour , subject receive either single oral dose test formulation , primidone ( 1 x 50 mg tablet ) single oral dose reference formulation , Mysoline® ( 1 x 50 mg tablet ) . After 14 day washout period , morning Day 15 overnight fast , subject receive alternate regimen . Blood sample draw participant dose 72 hour post dose time sufficient adequately define pharmacokinetics primidone . A goal study evaluate safety tolerability regimen healthy volunteer . Subjects monitor throughout confinement portion study adverse reaction study drug and/or procedure . Blood pressure heart rate obtain prior dose 3 , 4 , 6 , 24 72 hour post-dose . All adverse event whether elicited query , spontaneously report observed clinic staff evaluate investigator report subject 's case report form .</detailed_description>
	<mesh_term>Primidone</mesh_term>
	<criteria>male female least 18 year age weight must 15 % ideal weight height frame subject must good health physical condition determine medical history subject must read sign consent form history treatment alcoholism , substance abuse , drug abuse within last 24 month history malignancy , stroke , diabetes , cardiac , renal liver disease history gastroesophageal reflux disease ( GERD ) , malabsorption syndrome , colon cancer , chronic colitis , include Crohn 's disease history porphyria , hyperkinesia , respiratory disease ( eg . asthma , emphysema , difficulty breathing , pulmonary obstruction ) females pregnant lactate history hypersensitivity primidone , barbiturate , anticonvulsant sit systolic blood pressure 90mm Hg , diastolic pressure 50mm Hg ( condition upon screen might contraindicate require caution use administration primidone ) heart rate le 50 beat per minute 5 minute rest treatment investigational drug four week prior initial dose subject donate blood within four week prior initial dose subject smoke use tobacco product nicotine product . Three month abstinence require .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
</DOC>